Matthew D. Morgan

4.2k total citations · 1 hit paper
41 papers, 2.8k citations indexed

About

Matthew D. Morgan is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Genetics. According to data from OpenAlex, Matthew D. Morgan has authored 41 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 15 papers in Rheumatology and 13 papers in Genetics. Recurrent topics in Matthew D. Morgan's work include Vasculitis and related conditions (30 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (13 papers) and Otitis Media and Relapsing Polychondritis (6 papers). Matthew D. Morgan is often cited by papers focused on Vasculitis and related conditions (30 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (13 papers) and Otitis Media and Relapsing Polychondritis (6 papers). Matthew D. Morgan collaborates with scholars based in United Kingdom, Sweden and Canada. Matthew D. Morgan's co-authors include Caroline O.S. Savage, David Jayne, Vladimı́r Tesař, Lorraine Harper, Kerstin Westman, Raashid Luqmani, Michael Walsh, Mårten Segelmark, Rachel Jones and Jan Willem Cohen Tervaert and has published in prestigious journals such as New England Journal of Medicine, The Lancet and PLoS ONE.

In The Last Decade

Matthew D. Morgan

39 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

2010 1.1k citations Rachel Jones, Jan Willem Cohen Tervaert et al. profile →

Peers

Matthew D. Morgan

PRM

RHEUM

GENET

PHYSI

NEPHR

Aladdin J Mohammad Sweden

Ravi Suppiah United Kingdom

Gill Gaskin United Kingdom

Cristina Ponte Portugal

Joanna Robson United Kingdom

Hasan Yazıcı Türkiye

Sebastian Unizony United States

E. Reinhold‐Keller Germany

Sergio Prieto‐González Spain

Rachel Jones United Kingdom

Aladdin J Mohammad Sweden

Matthew D. Morgan

2.1k ×1.0

PRM

1.2k ×1.2

RHEUM

584 ×0.8

GENET

469 ×0.7

PHYSI

440 ×0.7

NEPHR

Citations per year, relative to Matthew D. Morgan Matthew D. Morgan (= 1×) peers Aladdin J Mohammad

Countries citing papers authored by Matthew D. Morgan

Since Specialization

Citations

This map shows the geographic impact of Matthew D. Morgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew D. Morgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew D. Morgan more than expected).

Fields of papers citing papers by Matthew D. Morgan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew D. Morgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew D. Morgan. The network helps show where Matthew D. Morgan may publish in the future.

Co-authorship network of co-authors of Matthew D. Morgan

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew D. Morgan. A scholar is included among the top collaborators of Matthew D. Morgan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew D. Morgan. Matthew D. Morgan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hepburn, David, et al.. (2025). Teaching routine person‐centred practice in medical education through medicines optimisation: A realist review. Medical Education. 59(11). 1172–1188.

Goldman, Inessa, et al.. (2024). A stent of strength: use of lumen-apposing metal stents (LAMS) for biliary pathologies and other novel applications. Abdominal Radiology. 50(2). 902–915. 1 indexed citations

Chanouzas, Dimitrios, J. Mcgregor, Peter Nightingale, et al.. (2019). Intravenous pulse methylprednisolone for induction of remission in severe ANCA associated Vasculitis: a multi-center retrospective cohort study. BMC Nephrology. 20(1). 58–58. 62 indexed citations

Druce, Katie L., Dimitrios Chanouzas, Matthew D. Morgan, et al.. (2019). The Longitudinal Course of Fatigue in Antineutrophil Cytoplasmic Antibody–associated Vasculitis. The Journal of Rheumatology. 47(4). 572–579. 11 indexed citations

Harper, Lorraine, Matthew D. Morgan, Dimitrios Chanouzas, et al.. (2018). Treatment of fatigue with physical activity and behavioural change support in vasculitis: study protocol for an open-label randomised controlled feasibility study. BMJ Open. 8(10). e023769–e023769. 15 indexed citations

Faustini, Sian, Charlotte N. Cook, Andrew McClean, et al.. (2018). Humoral immunity to memory antigens and pathogens is maintained in patients with chronic kidney disease. PLoS ONE. 13(4). e0195730–e0195730. 3 indexed citations

Chanouzas, Dimitrios, Peter Nightingale, Charles J. Ferro, et al.. (2016). Valaciclovir to prevent Cytomegalovirus mediated adverse modulation of the immune system in ANCA-associated vasculitis (CANVAS): study protocol for a randomised controlled trial. Trials. 17(1). 338–338. 12 indexed citations

Jones, Rachel, Shunsuke Furuta, Jan Willem Cohen Tervaert, et al.. (2015). Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial. Annals of the Rheumatic Diseases. 74(6). 1178–1182. 185 indexed citations

Hrušková, Zdenka, Mårten Segelmark, Matthew D. Morgan, et al.. (2015). Treatment of Severe Renal Disease in ANCA Positive and Negative Small Vessel Vasculitis with Rituximab. American Journal of Nephrology. 41(4-5). 296–301. 29 indexed citations

10.

Geetha, Duvuru, Zdenka Hrušková, Mårten Segelmark, et al.. (2015). Rituximab for treatment of severe renal disease in ANCA associated vasculitis. Journal of Nephrology. 29(2). 195–201. 31 indexed citations

11.

Croft, Adam P., Stuart W. Smith, Sue Carr, et al.. (2014). Successful outcome of pregnancy in patients with anti-neutrophil cytoplasm antibody–associated small vessel vasculitis. Kidney International. 87(4). 807–811. 20 indexed citations

12.

Morgan, Matthew D., Annette Pachnio, Jusnara Begum, et al.. (2011). CD4+CD28− T cell expansion in granulomatosis with polyangiitis (Wegener's) is driven by latent cytomegalovirus infection and is associated with an increased risk of infection and mortality. Arthritis & Rheumatism. 63(7). 2127–2137. 48 indexed citations

13.

Harper, Lorraine, Matthew D. Morgan, Michael Walsh, et al.. (2011). Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up. Annals of the Rheumatic Diseases. 71(6). 955–960. 276 indexed citations

14.

Fish, R. David, Jennifer H. Pinney, Poorva Jain, et al.. (2010). The Incidence of Major Hemorrhagic Complications After Renal Biopsies in Patients with Monoclonal Gammopathies. Clinical Journal of the American Society of Nephrology. 5(11). 1977–1980. 53 indexed citations

15.

Landray, Martin, Jonathan Emberson, Lisa Blackwell, et al.. (2010). Prediction of ESRD and Death Among People With CKD: The Chronic Renal Impairment in Birmingham (CRIB) Prospective Cohort Study. American Journal of Kidney Diseases. 56(6). 1082–1094. 127 indexed citations

16.

Smith, Helen, Andrew Bentall, Shazia Shabir, et al.. (2010). T Lymphocyte Responses to Nonpolymorphic HLA-Derived Peptides Are Associated With Chronic Renal Allograft Dysfunction. Transplantation. 91(3). 279–286. 8 indexed citations

17.

Morgan, Matthew D., Clara Day, Karen Piper Hanley, et al.. (2010). Patients with Wegener’s granulomatosis demonstrate a relative deficiency and functional impairment of T‐regulatory cells. Immunology. 130(1). 64–73. 95 indexed citations

18.

Flint, Julia, Matthew D. Morgan, & Caroline O. S. Savage. (2010). Pathogenesis of ANCA-associated Vasculitis. Rheumatic Disease Clinics of North America. 36(3). 463–477. 35 indexed citations

19.

Morgan, Matthew D., Umut Selamet, Peter Nightingale, et al.. (2009). Increased incidence of cardiovascular events in patients with antineutrophil cytoplasmic antibody–associated vasculitides: A matched‐pair cohort study. Arthritis & Rheumatism. 60(11). 3493–3500. 103 indexed citations

20.

Morgan, Matthew D., Lorraine Harper, Julie Williams, & Caroline O.S. Savage. (2006). Anti-Neutrophil Cytoplasm-Associated Glomerulonephritis. Journal of the American Society of Nephrology. 17(5). 1224–1234. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact